Please provide your email address to receive an email when new articles are posted on . DALLAS — Results presented at the American Association of Hip and Knee Surgeons Annual Meeting showed all dosing ...
Please provide your email address to receive an email when new articles are posted on . LAS VEGAS — Several tranexamic acid-dosing regimens yielded equivalent blood-sparing properties when used in ...
Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, today announced it has ...
Topical and intravenous tranexamic acid (TXA) were found to significantly reduce blood loss compared with placebo in patients who have undergone bone surgery, suggesting that both administration ...
The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...
Tranexamic acid reduces the risk of bleeding among patients undergoing cardiac surgery, but it is unclear whether this leads to improved outcomes. Furthermore, there are concerns that tranexamic acid ...
Perioperative bleeding is common in patients undergoing noncardiac surgery. Tranexamic acid is an antifibrinolytic drug that may safely decrease such bleeding. We conducted a trial involving patients ...
Tranexamic acid is used to control heavy menstrual bleeding. It’s available as a brand-name drug called Lysteda. You can get it only with a doctor’s prescription. Heavy or prolonged menstrual bleeding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results